Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Dr Gunaratnam says it can be particularly useful for those transitioning off injectable GLP-1 drugs
Wang Y, Xu J, Fan Z, Zhou X, Wang Z, Zhang H
Key Points: GI symptoms are the most common adverse effects, ranging from expected nausea and vomiting to gastroparesis and, rarely, functional obstruction Delayed gastric emptying has important airway implications and a cautious approach to airway management is warranted Biliary disease is one of the most clinically significant complications, particularly early in treatment and with rapid weight loss Pancreatitis is rare, and current evidence does not support a strong causal relationship EDKA and AKI are uncommon but important to recognize in the right context Conclusions: GLP-1 receptor agonists have transformed the management of diabetes and obesity, with clear benefits in weight loss, glycemic control, and cardiovascular outcomes
Contact your GP if you experience persistent insomnia lasting more than 23 weeks, symptoms of nocturnal hypoglycaemia, severe gastrointestinal symptoms disrupting sleep, or excessive daytime fatigue interfering with daily activities
10.1371/journal.pone.0008380 81 NicholsH
US$ 29.00
US$ 28.61
US$ 21.88
)
US$ 29.36
